OTCMKTS:IMRSQ - IMRIS Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week Range$0.0001 - $0.0040
Volume500 shs
Average Volume500 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-2.68
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.

Receive IMRSQ News and Ratings via Email

Sign-up to receive the latest news and ratings for IMRSQ and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IMRSQ
Previous SymbolNASDAQ:IMRS
CUSIPN/A
Phone763-203-6300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees121
Next Earnings DateN/A
OptionableNot Optionable

IMRIS (OTCMKTS:IMRSQ) Frequently Asked Questions

What is IMRIS's stock symbol?

IMRIS trades on the OTCMKTS under the ticker symbol "IMRSQ."

Has IMRIS been receiving favorable news coverage?

Media coverage about IMRSQ stock has been trending neutral recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. IMRIS earned a media sentiment score of 0.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of IMRIS's key competitors?

What other stocks do shareholders of IMRIS own?

Who are IMRIS's key executives?

IMRIS's management team includes the folowing people:
  • Mr. Maurice L. Holloman, Exec. VP of Operations - Customer Support & Customer Engineering
  • Mr. Andrew M. Flanagan, CEO & Pres
  • Mr. Robert C. Korn, Sr. VP of Global Sales and Marketing (Age 54)
  • Mr. Peter Simpson, Sr. VP of R&D

How do I buy shares of IMRIS?

Shares of IMRSQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IMRIS's official website?

The official website for IMRIS is http://www.imris.com/.

How can I contact IMRIS?

IMRIS's mailing address is 5101 SHADY OAK RD, MINNETONKA MN, 55343. The company can be reached via phone at 763-203-6300 or via email at [email protected]


MarketBeat Community Rating for IMRIS (OTCMKTS IMRSQ)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  107 (Vote Outperform)
Underperform Votes:  106 (Vote Underperform)
Total Votes:  213
MarketBeat's community ratings are surveys of what our community members think about IMRIS and other stocks. Vote "Outperform" if you believe IMRSQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMRSQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Featured Article: Straddles

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel